| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 27 Nov 2024 | 21 Dec 2024 |
| Issuing a notice convening an extra-ordinary general meeting on 21st December 2024 for, inter alia, seeking shareholders approval for inter alia matters listed out Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on December 21, 2024. Further, the company has informed the Exchange regarding voting results. (As Per NSE Announcement Dated on: 21/12/2024) Beta Drugs Limited has informed the Exchange with copy of minutes of Extraordinary General Meeting held on December 21, 2024 (As Per NSE Announcement Dated on: 27/12/2024) | ||
| EGM | 19 Oct 2024 | 12 Nov 2024 |
| Beta Drugs Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on November 12, 2024 Beta Drugs Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on November 12, 2024 (As Per NSE Announcement Dated on: 12/11/2024) Beta Drugs Limited has informed the Exchange regarding voting results of Extraordinary General Meeting held on November 12, 2024 (As Per NSE Announcement Dated on: 13/11/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
